Broadway Wealth Solutions’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$517K Buy
431
+19
+5% +$19.4K 0.24% 34
2026
Q1
$379K Buy
412
+4
+1% +$4.05K 0.2% 44
2025
Q4
$438K Sell
408
-67
-14% -$64.1K 0.23% 37
2025
Q3
$362K Buy
475
+29
+7% +$21.6K 0.2% 46
2025
Q2
$348K Buy
446
+29
+7% +$22.5K 0.22% 42
2025
Q1
$344K Sell
417
-54
-11% -$44.9K 0.25% 37
2024
Q4
$363K Buy
+471
New +$390K 0.28% 40

Other funds holding LLY

Broadway Wealth Solutions's LLY Position: Q2 2026 in Review

Broadway Wealth Solutions increased its Eli Lilly (LLY) stake by 4.6% in Q2 2026, buying an estimated $19.4K and bringing the position to 431 shares worth $517K. The position accounts for 0.24% of the portfolio, ranked #34.

Broadway Wealth Solutions first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Broadway Wealth Solutions held 431 shares of Eli Lilly worth $517K as of Q2 2026.
  • Broadway Wealth Solutions bought 19 Eli Lilly shares in Q2 2026, an estimated $19.4K.
  • Eli Lilly made up 0.24% of Broadway Wealth Solutions's portfolio in Q2 2026, its #34 holding.
  • Broadway Wealth Solutions first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Broadway Wealth Solutions's 13F filing for Q2 2026, filed 13 Jul 2026.